Immunocore

Immunocore

Primary Menu

  • About us
    • Management Team
    • Board of Directors
    • Partners
  • Our science
    • Pipeline
    • Publications
    • Scientific Advisory Board
  • Our therapy areas
    • Oncology
    • Infectious Diseases
    • Autoimmune and Inflammation Diseases
  • For patients
  • News
  • Contact us
  • Careers

Primary Menu

  • About us
  • Our science
  • Our therapy areas
  • For patients
  • News
  • Contact us
  • Careers
  1. Home
  2. /
  3. News

News

  • 6 August 2015

    The Royal Society publishes a video case study on Immunocore
  • 29 July 2015

    Immunocore announces Fidelity’s Participation in $320M Financing
  • 16 July 2015

    Immunocore secures $320 million (£205 million) in Europe’s Largest Private Life Sciences Financing
  • 9 July 2015

    Chief Executive Eliot Forster’s interview with Consilium Strategic Communications
  • 29 June 2015

    Immunocore and Lilly announce immunotherapy-based clinical trial collaboration in melanoma
  • 12 June 2015

    Immunocore Wins Emerging Star of the Year Award at the European Mediscience Awards 2015
  • 28 May 2015

    Dr. Bent Jakobsen, Immunocore’s Chief Scientific Officer, elected to the Fellowship of the Academy of Medical Sciences
  • 11 May 2015

    Immunocore to attend Citi European Healthcare Conference 2015 and BioTrinity 2015
  • 20 April 2015

    Immunocore Announces Positive Clinical Trial Data for Novel First-in-Class Immunotherapy at AACR Annual Meeting 2015
  • 16 April 2015

    Immunocore and MedImmune announce new collaboration to conduct immuno-oncology combination trials in melanoma
  • ← Previous
  • 1
  • …
  • 4
  • 5
  • 6
  • 7 (current)
  • 8
  • 9
  • 10
  • 11
  • Next →

Sign up to receive news email alerts

News archive
  • Show all
  • 2021 (1)
  • 2020 (8)
  • 2019 (13)
  • 2018 (10)
  • 2017 (13)
  • 2016 (11)
  • 2015 (20)
  • 2014 (6)
  • 2013 (11)
  • 2012 (3)
  • 2011 (1)
  • 2010 (4)
  • 2009 (1)
  • 2008 (1)

Immunocore

Immunocore
  • About us
  • Our science
  • Our therapy areas
  • For patients
  • News
  • Contact us
  • Privacy and Social Media Guidelines
  • Cookies
  • Payments and Disclosures
  • Clinical trials

©2021 Immunocore, Ltd. All rights reserved. ImmTAC, ImmTAV, ImmTAB, ImmTAAI and ImmTAX are all registered trademarks of Immunocore, Ltd